Overview: transplantation tolerance--challenges and opportunities for drug development
Dumont, F.J.
Current Opinion in Investigational Drugs 3(10): 1453-1457
2002
ISSN/ISBN: 1472-4472 PMID: 12431017 Document Number: 542100
Document emailed within 1 workday
Related Documents
Schaub, S.; Wilkins, J.A.; Nickerson, P. 2004: Proteomics in renal transplantation: opportunities and challenges Clinical Transplants 2004: 253-260Williams, M. 2000: Drug discovery in a new century: mechanistic opportunities and therapeutic challenges Current Opinion in Investigational Drugs 1(1): I-Iii
Mouchet, E.H.; Simpson, P.B. 2008: High-content assays in oncology drug discovery: opportunities and challenges Idrugs: the Investigational Drugs Journal 11(6): 422-427
Solomon, H. 2011: Opportunities and challenges of expanded criteria organs in liver and kidney transplantation as a response to organ shortage Missouri Medicine 108(4): 269-274
Wirtz, V.J.; Dreser, Aí.; Heredia-Pi, I. 2013: Challenges and opportunities for the development of a national pharmaceutical policy in México Salud Publica de Mexico 55(3): 329-336
Josephine Para-Mallam, O 2006: Faith, gender and development agendas in Nigeria: conflicts, challenges, and opportunities Gender and Development 14(3): 409-421
Sugavanam, B. 1996: Risk reduction in pesticide development in developing countries: Challenges and opportunities Journal of Environmental Science and Health Part B Pesticides Food Contaminants and Agricultural Wastes 31(3): 307-323
Wijayanti, F.; Tarmizi, S.Nadia.; Tobing, V.; Nisa, T.; Akhtar, M.; Trihandini, I.; Djuwita, R. 2016: From the Millennium Development Goals to Sustainable Development Goals.: The response to the HIV epidemic in Indonesia: challenges and opportunities Journal of Virus Eradication 2(Suppl. 4): 27-31
DiGirolamo, A.M.; Stansbery, P.; Lung'aho, M. 2014: Advantages and challenges of integration: opportunities for integrating early childhood development and nutrition programming Annals of the new York Academy of Sciences 1308: 46-53
DiGirolamo, A.M.; Stansbery, P.; Lung'aho, M. 2014: Advantages and challenges of integration: opportunities for integrating early childhood development and nutrition programming Annals of the new York Academy of Sciences 1308: 46-53
Saitovitch, D.; Bushell, A.R.; Morris, P.J.; Wood, K.J. 1995: Induction of transplantation tolerance using a nondepleting anti-CD4 MAb and donor-specific transfusion before transplantation: evidence that a critical period of time is required for the development of immunological unresponsiveness Transplantation Proceedings 27(1): 117-118
Zhang, Q-Wei.; Tomita, Y.; Matsuzaki, G.; Shimizu, I.; Iwai, T.; Okano, S.; Minagawa, R.; Nakashima, Y.; Sueishi, K.; Nomoto, K.; Yasui, H. 2002: Heart allograft tolerance without development of posttransplant cardiac allograft vasculopathy in chimerism-based, drug-induced tolerance Transplantation 73(4): 652-656
Keith, J.A.; Agostini Bigger, L.; Arthur, P.A.; Maes, E.; Daems, R. 2013: Delivering the promise of the Decade of Vaccines: opportunities and challenges in the development of high quality new vaccines Vaccine 31(Suppl 2): B184-B193
Ford, A.Q.; Touchette, N.; Hall, B.Fenton.; Hwang, A.; Hombach, J. 2016: Global Vaccine and Immunization Research Forum: Opportunities and challenges in vaccine discovery, development, and delivery Vaccine 34(13): 1489-1495
Blue Bird Jernigan, V.; Brokenleg, I.'Shaneequa'.; Burkhart, M.; Magdalena, C.; Sibley, C.; Yepa, K. 2014: The implementation of a participatory manuscript development process with Native American tribal awardees as part of the CDC Communities Putting Prevention to Work initiative: challenges and opportunities Preventive Medicine 67 Suppl. 1: S51-S57
Adamson, P.C. 2017: Challenges in drug development for children Clinical Advances in Hematology and Oncology: H&o 15(1): 26-29
Light, J.; McNaughton, D.; Beukelman, D.; Fager, S.Koch.; Fried-Oken, M.; Jakobs, T.; Jakobs, E. 2019: Challenges and opportunities in augmentative and alternative communication: Research and technology development to enhance communication and participation for individuals with complex communication needs Augmentative and Alternative Communication 35(1): 1-12
Light, J.; McNaughton, D.; Beukelman, D.; Fager, S.Koch.; Fried-Oken, M.; Jakobs, T.; Jakobs, E. 2019: Challenges and opportunities in augmentative and alternative communication: Research and technology development to enhance communication and participation for individuals with complex communication needs Augmentative and Alternative Communication 35(1): 1-12
Hölscher, M. 1984: Tolerance to ischemia in in-situ operations and kidney transplantation. Development of a protective procedure Fortschritte der Medizin 102(44): 1138-1140
Castaldi, G. 1975: Study of lactase activity in the development of hepatobiliary drug tolerance Giornale di Clinica Medica 56(5-6): 218-225